Older adults respond well to immunotherapy despite age-related immune system differences, researchers find

by

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins Convergence Institute.

Leave A Comment

Your email address will not be published. Required fields are marked *